Letter | Published:

Macrophages on intrauterine contraceptive devices produce prostaglandins

Naturevolume 257pages227228 (1975) | Download Citation



THE mechanisms whereby intrauterine contraceptive devices (IUDs) exert their anti-fertility effects remains unestablished1. The involvement of prostaglandins (PGs) is being investigated2–5, although alternative mechanisms have been proposed (for example, phagocytic and other actions of macrophages6,7). Although the relative contributions of macrophages and PGs to the anti-fertility actions of IUDs remains uncertain, it is clear that introduction of the IUD into the endometrial cavity results in an infiltration by neutrophils and macrophages8 as well as increased PG levels in uterine venous blood in animals9,10. While investigating the role of mediators of chronic inflammation we have demonstrated that the macrophage is a potent source of PGE11, and since the macrophage is the predominant cell adhering to the IUD6 we have considered the possibility that such cells act as a source of PGs.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Thompson, I. E., Obstet. Gynec., 42, 617 (1973).

  2. 2

    Kirton, K. T., Phariss, B. B., and Forbes, A. D., Proc. exp. Biol. Med., 133, 314 (1970).

  3. 3

    McCracken, J. A., Ann. N. Y. Acad. Sci., 180, 456 (1971).

  4. 4

    Powell, W. S., Hammerström, S., Samuelsson, B., and Stöberg, B., Lancet, i, 1120 (1974).

  5. 5

    Batta, S. K., and Martini, L., Prostaglandins, 6, 329 (1974).

  6. 6

    Saǧiroǧlu, N., and Saǧiroǧlu, E., Am. J. Obstet. Gynec., 106, 506 (1970).

  7. 7

    Moyer, D. L., and Mishell, D. R., Am. J. Obstet. Gynec., III, 66 (1971).

  8. 8

    Tatum, H. J., Am. J. Obstet. Gynec., 112, 1000 (1972).

  9. 9

    Poyser, N. L., Horton, E. W., and Thompson, C. J., Nature, 230, 526 (1971).

  10. 10

    Spilman, C. H., and Duby, R. T., Prostaglandins, 2, 159 (1972).

  11. 11

    Bray, M. A., Gordon, D., and Morley, J., Br. J. Pharmac., 52, 453P (1974).

  12. 12

    Brummer, H. C., Prostaglandins, 2, 185 (1972).

  13. 13

    Lee, R. E., and Lands, W. E. M., Biochim. biophys. Acta, 260, 203 (1972).

  14. 14

    Nugteren, D. H., Beerthuis, R. K., and Dorp, D. A. van, Rec. Trav. Chim. Pays-Bas, 85, 405 (1966).

  15. 15

    Vernon-Roberts, B., Int. Rev. Cytol., 25, 131 (1969).

  16. 16

    Zurier, R. B., Proc. Second int. Conf. Prostaglandins (edit. by Samuelsson, B., and Paoletti, R.), (in the press).

  17. 17

    Higgs, G. A., and Youlten, L. J. F., Br. J. Pharmac., 44, 330P (1972).

  18. 18

    Morley, J., Bray, M. A., Gordon, D., and Paul, W., in Immunological Basis of Connective Tissue Disorders: fifth Lepetit Colloquium (edit. by Silvestri, L. G.), 129 (North Holland, Amsterdam, 1975).

  19. 19

    Blatchley, F. R., Donovan, B. J., Horton, E. W., and Poyser, N. L., J. Physiol., Lond., 223, 69 (1972).

Download references

Author information


  1. Department of Obstetrics and Gynaecology, Charing Cross Hospital Medical School, London, W6

    • L. MYATT
  2. Laboratory of Applied Physiology, Kennedy Institute of Rheumatology, Bute Gardens, London, W6 7DW, UK

    • M. A. BRAY
    • , D. GORDON
    •  & J. MORLEY


  1. Search for L. MYATT in:

  2. Search for M. A. BRAY in:

  3. Search for D. GORDON in:

  4. Search for J. MORLEY in:

About this article

Publication history



Issue Date



Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.